Home/Filings/4/0001214659-23-006373
4//SEC Filing

Jackman Stephan 4

Accession 0001214659-23-006373

CIK 0001677077other

Filed

May 1, 8:00 PM ET

Accepted

May 2, 4:30 PM ET

Size

5.1 KB

Accession

0001214659-23-006373

Insider Transaction Report

Form 4
Period: 2023-04-28
Jackman Stephan
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2023-04-28$0.54/sh+37,000$19,99945,500 total
Footnotes (1)
  • [F1]The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.5405. The range of purchase prices on the transaction date was $0.5398 to $0.5499 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

Issuer

Alzamend Neuro, Inc.

CIK 0001677077

Entity typeother

Related Parties

1
  • filerCIK 0001864257

Filing Metadata

Form type
4
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:30 PM ET
Size
5.1 KB